NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.

J Natl Compr Canc Netw 2017 01;15(1):9-20

National Comprehensive Cancer Network

The NCCN Clinical Practice Guidelines in Oncology for Genetic/Familial High-Risk Assessment: Breast and Ovarian provide recommendations for genetic testing and counseling for hereditary cancer syndromes and risk management recommendations for patients who are diagnosed with a syndrome. Guidelines focus on syndromes associated with an increased risk of breast and/or ovarian cancer. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. The NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding risk management for carriers of moderately penetrant genetic mutations associated with breast and/or ovarian cancer.

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2017.0003DOI Listing
January 2017
80 Reads

Publication Analysis

Top Keywords

genetic/familial high-risk
12
assessment breast
12
high-risk assessment
12
breast ovarian
12
ovarian cancer
8
risk management
8
and/or ovarian
8
breast and/or
8
guidelines insights
8
nccn guidelines
8
breast
5
ovarian
5
abstracts reevaluate
4
diagnosed syndrome
4
syndrome guidelines
4
guidelines focus
4
focus syndromes
4
nccn
4
publications abstracts
4
reevaluate update
4

Similar Publications